STAG3L1: A Drug Target / Disease Biomarker (G54441)

Target Name: STAG3L1

NCBI ID: G54441

STAG3L1

STAG3L1: A Drug Target / Disease Biomarker

STAG3L1, also known as STAG-3L1, is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell-cell adhesion, which is the process by which cells stick together to form tissues and organs. STAG3L1 has also been shown to play a role in the development and progression of various diseases, including cancer. As a result, STAG3L1 has become a focus of interest for researchers looking for new treatments for these diseases.

One of the key features of STAG3L1 is its ability to regulate cell-cell adhesion. This process is critical for the development and maintenance of tissues and organs, and it is also involved in the formation of various signaling pathways that regulate cell behavior. STAG3L1 plays a key role in these processes by regulating the interactions between cells and the extracellular matrix (ECM), which is the matrix of proteins and other molecules that makes up the tissue.

STAG3L1 has been shown to be involved in the regulation of cell-cell adhesion in various tissues and organs. For example, studies have shown that STAG3L1 plays a role in the regulation of tight junction formation, which is the process by which cells stick together to form tissues and organs. tight junction formation is critical for the development and maintenance of tissues such as blood vessels and epithelial tissues, and it is also involved in the regulation of various signaling pathways that control cell behavior.

In addition to its role in cell-cell adhesion, STAG3L1 has also been shown to be involved in the regulation of cell-extracellular matrix (EXTECM) interactions. This process is critical for the development and maintenance of tissues and organs, and it is also involved in the regulation of various signaling pathways that control cell behavior. STAG3L1 plays a key role in these processes by regulating the interactions between cells and the ECM, which is the matrix of proteins and other molecules that makes up the tissue.

STAG3L1 has also been shown to be involved in the regulation of various signaling pathways that control cell behavior. For example, studies have shown that STAG3L1 plays a role in the regulation of the Wnt signaling pathway, which is a signaling pathway that is involved in the development and maintenance of tissues and organs. Wnt signaling is critical for the development and maintenance of tissues such as neural networks and organs, and it is also involved in the regulation of various signaling pathways that control cell behavior.

In conclusion, STAG3L1 is a protein that is involved in various processes that are critical for the development and maintenance of tissues and organs. Its role in cell-cell adhesion, cell-EXTECM interactions, and the regulation of various signaling pathways makes it an attractive target for researchers looking for new treatments for diseases such as cancer. Further research is needed to fully understand the role of STAG3L1 in these processes and to develop effective treatments for these diseases.

Protein Name: Stromal Antigen 3-like 1 (pseudogene)

The "STAG3L1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STAG3L1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets